Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mr Prasanna Sooriakumaran, a Senior Clinical Researcher in Robotic Surgery and Urology at the Nuffield Department of Surgical Sciences, has been awarded The Urology Foundation (TUF) medal for ‘Best Research Proposal’ of 2016.

Mr Prasanna Sooriakumaran has been awarded The Urology Foundation (TUF) medal for ‘Best Research Proposal’ of 2016. © TUF
Mr Prasanna Sooriakumaran has been awarded The Urology Foundation (TUF) medal for ‘Best Research Proposal’ of 2016.

Every year TUF looks to fund crucial urology research into diseases like prostate cancer. Mr Sooriakumaran will receive £50,000 through The Urology Foundation Research Scholarship Programme to fund his research project ‘Testing radical prostatectomy in men with prostate cancer and oligo metastases to the bone: a randomised controlled feasibility study.’

Mr Prasanna Sooriakumaran has been awarded The Urology Foundation (TUF) medal for ‘Best Research Proposal’.© NDSThis funding, along with the 2015 Young Investigator Award worth $225,000 which Mr Sooriakumaran received from the Prostate Cancer Foundation, will be used to fund the TRoMbone clinical trial.

TRoMbone will study whether patients can be recruited into a trial that compares current standard care for treating oligo-metastatic prostate cancer (currently androgen deprivation therapy (ADT)) plus radical prostatectomy to standard care alone. TRoMbone is a feasibility study with an embedded Qualitative Recruitment Investigation (QRI), which will optimise recruitment methods for the trial. Should this feasibility trial show that recruitment is possible in this cohort of men, a further funding application will be prepared for a larger study to look at treatment effects. TRoMbone is currently in set-up, with an anticipated start date of 1 October 2016.

Mr Sooriakumaran was presented with the TUF medal at the BAUS (British Association of Urological Surgeons) Annual Meeting, which took place on Wednesday 29 June 2016.

‘I'm honoured to have received this medal,' he said. 'Thanks to the generosity of The Urology Foundation, we can now investigate the role of surgery in men with limited metastatic prostate cancer, which could potentially have huge impact for how we treat these men.’

Similar stories

Professor Peter McCulloch receives NIHR Senior Investigator Award

Awards and appointments

We are delighted to announce that Professor Peter McCulloch of the Nuffield Department of Surgical Sciences has been awarded the title of NIHR Senior Investigator.

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.